Cognitive load of walking in people who are blind: Subjective and objective measures for assessment

Publication date: Available online 24 September 2018

Source: Gait & Posture

Author(s): Caroline Pigeon, Tong Li, Fabien Moreau, Gilbert Pradel, Claude Marin-Lamellet

Abstract

Background

Although walking without vision seems to carry a high cognitive cost, few studies have measured the cognitive load involved in this activity in blind people. The aim of this study was to assess the cognitive load of walking in blind people, using gait analysis, a dual task paradigm and a subjective assessment of cognitive load.

Methods

In a quantitative quasi-experimental design, 25 blind adults walked 40 meters. In one trial, participants walked normally (control condition). In another, they walked while performing an auditory simple reaction time task, and in the third trial they walked, performed the simple reaction time task and avoided obstacles. In addition to the simple reaction time task performance, walking speed was recorded, and participants provided a subjective assessment of cognitive load after each trial. Performance of participants aged less than 60 years were compared with those aged over than 60 years.

Results

Walking significantly reduced performance of the simple reaction time task; carrying out the simple reaction time task while walking significantly reduced walking performance and increased the subjective assessment of cognitive load; and simple reaction time task performance decreased and subjective assessment increased when obstacles were present. Few significant age effects were found.

Significance

Walking without vision involves a cognitive load that increases when the environment becomes complex. Each of the three methods used is relevant when assessing the cognitive load involved in walking in blind people, and could be useful in rehabilitation intervention. The results obtained allowed recommendations to be suggested for the design of technological mobility devices.

from #Audiology via ola Kala on Inoreader https://ift.tt/2IccT5Q
via IFTTT

Cognitive load of walking in people who are blind: Subjective and objective measures for assessment

Publication date: Available online 24 September 2018

Source: Gait & Posture

Author(s): Caroline Pigeon, Tong Li, Fabien Moreau, Gilbert Pradel, Claude Marin-Lamellet

Abstract

Background

Although walking without vision seems to carry a high cognitive cost, few studies have measured the cognitive load involved in this activity in blind people. The aim of this study was to assess the cognitive load of walking in blind people, using gait analysis, a dual task paradigm and a subjective assessment of cognitive load.

Methods

In a quantitative quasi-experimental design, 25 blind adults walked 40 meters. In one trial, participants walked normally (control condition). In another, they walked while performing an auditory simple reaction time task, and in the third trial they walked, performed the simple reaction time task and avoided obstacles. In addition to the simple reaction time task performance, walking speed was recorded, and participants provided a subjective assessment of cognitive load after each trial. Performance of participants aged less than 60 years were compared with those aged over than 60 years.

Results

Walking significantly reduced performance of the simple reaction time task; carrying out the simple reaction time task while walking significantly reduced walking performance and increased the subjective assessment of cognitive load; and simple reaction time task performance decreased and subjective assessment increased when obstacles were present. Few significant age effects were found.

Significance

Walking without vision involves a cognitive load that increases when the environment becomes complex. Each of the three methods used is relevant when assessing the cognitive load involved in walking in blind people, and could be useful in rehabilitation intervention. The results obtained allowed recommendations to be suggested for the design of technological mobility devices.

from #Audiology via ola Kala on Inoreader https://ift.tt/2IccT5Q
via IFTTT

The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.

The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.

J Clin Neurosci. 2018 Sep 19;:

Authors: Monroe JD, Millay MH, Patty BG, Smith ME

Abstract
Cisplatin is a widely used chemotherapy drug that can damage auditory and vestibular tissue and cause hearing and balance loss through the intracellular release of reactive oxygen species (ROS). Curcumin has anticancer efficacy and can also counteract cisplatin's damaging effect against sensory tissue by scavenging intracellular ROS, but curcumin's applicability is limited due to its low bioavailability. EF-24 is a synthetic curcumin analog that is more bioavailable than curcumin and can target cancer, but its effects against cisplatin-mediated ROS in auditory and vestibular tissue is currently unknown. In this study, we employed a novel zebrafish inner ear tissue culture system to determine if EF-24 counteracted cisplatin-mediated ROS release in two sensory endorgans, the saccule and the utricle. The zebrafish saccule is associated with auditory function and the utricle with vestibular function. Trimmed endorgans were placed in tissue culture media with a fluorescent reactive oxygen species indicator dye, and intracellular ROS release was measured using a spectrophotometer. We found that cisplatin treatment significantly increased ROS compared to controls, but that EF-24 treatment did not alter or even decreased ROS. Importantly, when equimolar cisplatin and EF-24 treatments are combined, ROS did not increase compared to controls. This suggests that EF-24 may be able to prevent intracellular ROS caused by cisplatin treatment in inner ear tissue.

PMID: 30243600 [PubMed - as supplied by publisher]

from #Audiology via ola Kala on Inoreader https://ift.tt/2I9nG0r
via IFTTT

The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.

The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.

J Clin Neurosci. 2018 Sep 19;:

Authors: Monroe JD, Millay MH, Patty BG, Smith ME

Abstract
Cisplatin is a widely used chemotherapy drug that can damage auditory and vestibular tissue and cause hearing and balance loss through the intracellular release of reactive oxygen species (ROS). Curcumin has anticancer efficacy and can also counteract cisplatin's damaging effect against sensory tissue by scavenging intracellular ROS, but curcumin's applicability is limited due to its low bioavailability. EF-24 is a synthetic curcumin analog that is more bioavailable than curcumin and can target cancer, but its effects against cisplatin-mediated ROS in auditory and vestibular tissue is currently unknown. In this study, we employed a novel zebrafish inner ear tissue culture system to determine if EF-24 counteracted cisplatin-mediated ROS release in two sensory endorgans, the saccule and the utricle. The zebrafish saccule is associated with auditory function and the utricle with vestibular function. Trimmed endorgans were placed in tissue culture media with a fluorescent reactive oxygen species indicator dye, and intracellular ROS release was measured using a spectrophotometer. We found that cisplatin treatment significantly increased ROS compared to controls, but that EF-24 treatment did not alter or even decreased ROS. Importantly, when equimolar cisplatin and EF-24 treatments are combined, ROS did not increase compared to controls. This suggests that EF-24 may be able to prevent intracellular ROS caused by cisplatin treatment in inner ear tissue.

PMID: 30243600 [PubMed - as supplied by publisher]

from #Audiology via ola Kala on Inoreader https://ift.tt/2I9nG0r
via IFTTT